NEW YORK (GenomeWeb News) — The Industrial Technology Research Institute and Vita Genomics will market their pharmacogenomics services to drug developers, Vita said today.
 
Under the agreement, the companies plan to offer Vita’s high-throughput sequencing, genotyping, and gene-expression profiling, and ITRI’s proteomics databases to pharmaceutical companies.
 
Both shops are based in Taiwan. Vita has a marketing operation in the US.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.